WALTHAM, Mass.--(BUSINESS WIRE)--OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a leading developer of biopharmaceutical compounds to treat cancer and certain ophthalmologic diseases, announced today that Dr. Richard Chin, its President and Chief Executive Officer, will present at the Lazard Capital Markets Third Annual Life Sciences Conference at The New York Palace in New York, NY. Dr. Chin will present on Wednesday, November 29, 2006 at 10:30am ET. A live and archived webcast of the presentation can be accessed at http://www.wsw.com/webcast/lz3/oxgn/
